Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | MAFF |
| Upstream (Parents) |
|---|
| (<<) ADRBK1 → MAFF |
| (<<) COL13A1 → MAFF |
| (<<) GNAI2 → MAFF |
| (<<) GPR109B → MAFF |
| (<<) IL6 → MAFF |
| (<<) JUN → MAFF |
| (<<) MAP3K8 → MAFF |
| (<<) MYO10 → MAFF |
| (<<) NDRG1 → MAFF |
| (<<) NFATC1 → MAFF |
| (<<) PDK2 → MAFF |
| (<<) PIM1 → MAFF |
| (<<) PTGS2 → MAFF |
| (<<) PTK2B → MAFF |
| (<<) PTPLA → MAFF |
| (<<) SH3GLB2 → MAFF |
| (<<) SPR → MAFF |
| (<<) STX12 → MAFF |
| (<<) TM4SF1 → MAFF |
| Downstream (Children) |
|---|
| MAFF → ANGPTL4 (>>) |
| MAFF → ARSJ (>>) |
| MAFF → CEBPD (>>) |
| MAFF → CHI3L1 (>>) |
| MAFF → CXCL1 (>>) |
| MAFF → CXCL2 (>>) |
| MAFF → CXCL3 (>>) |
| MAFF → EGF (>>) |
| MAFF → EGR1 (>>) |
| MAFF → ERRFI1 (>>) |
| MAFF → ETS2 (>>) |
| MAFF → FOXA2 (>>) |
| MAFF → HS3ST1 (>>) |
| MAFF → IL1B (>>) |
| MAFF → KCNJ2 (>>) |
| MAFF → LEMD1 (>>) |
| MAFF → LIF (>>) |
| MAFF → MMP9 (>>) |
| MAFF → NCOA7 (>>) |
| MAFF → PFKFB3 (>>) |
| MAFF → PHLDA1 (>>) |
| MAFF → PPP1R15B (>>) |
| MAFF → RAB7B (>>) |
| MAFF → RASD1 (>>) |
| MAFF → SLC5A1 (>>) |
| MAFF → SP5 (>>) |
| MAFF → UAP1 (>>) |
